Folate Metabolism Gene 5,10-Methylenetetrahydrofolate Reductase (MTHFR) Is Associated with ADHD in Myelomeningocele Patients

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Spellicy, Catherine J ^a   Northrup, Hope ^a,b   Fletcher, Jack M ^c   Cirino, Paul T ^c   Dennis, Maureen ^d   Morrison, Alanna C ^e   Martinez, Carla A ^f   Au, Kit Sing ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Shriners Hospital for Children   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

3' UNTRANSLATED REGION; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; FEMALE; FOLATE METABOLISM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; MTHFR GENE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR; CASE-CONTROL STUDIES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MENINGOMYELOCELE; METABOLIC NETWORKS AND PATHWAYS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84870789678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051330     Document Type: Article

References (47)

1. Chen B, Carmichael S, Selvin S, Abrams B, Shaw G, (2008) NTD prevalences in central California before and after folic acid fortification. Birth Defects Res A: Clin Mol Terat 82(8): 547-552.
2. Canfield M, Marengo L, Ramadhani T, Suarez L, Brender J, et al. (2009) The prevalence and predictors of anencephaly and spina bifida in Texas. Paediatr Perinat Epidem 23(1): 41-50.
3. Parker S, Mai C, Canfield M, Rickard R, Wang Y, et al. (2010) Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A: Clin Mol Teratol 88(12): 1008-1016.
4. Agiopian A, Canfield M, Olney R, Lupo P, Ramadhani T, et al. (2011) Spina bifida subtypes and sub-phenotypes by maternal race/ethnicity in the National Birth Defects Prevention Study. Am J Med Genet Part A. 9999: 1-7.
5. NINDS NIH (2007) "Spina bifida fact sheet." Retrieved November 29, 2011, from http://www.ninds.nih.gov/disorders/spina_bifida/detail_spina_bifida.htm.
6. Morgan D, Blackburn M, Bax M, (1995) Adults with spina bifida and/or hydrocephalus. Postgrad Med J 71: 17-21.
7. Burmeister R, Hannay H, Copeland K, Fletcher JM, Boudousquie A, et al. (2005) Attention problems and executive functions in children with spina bifida and hydrocephalus. Child Neuropsych 11: 265-283.
8. Ammerman R, Kane V, Slomka G, Reigel D, Franzen M, et al. (1998) Psychiatric symptomatology and family functioning in children and adolescents with spina bifida. J Clin Psych Med Settings 5: 449-465.
9. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131.
10. Food and Drug Administration (2006) Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule, 21 CFR parts 136,137 and 139.
11. Kuznetsova AY, Deth RC, (2008) A model for modulation of neuronal synchronization by D4 dopamine receptor-mediated phospholipid methylation. J Comput Neurosci 24: 314-329.
12. Zhao R, Chen Y, Tan W, Waly M, Sharma A, et al. (2001) Relationship between dopamine-stimulated phospholipid methylation and the single-carbon folate pathway. J Neurochem 78: 788-796.
13. Brookes KJ, Xu X, Chen W, Zhou K, Neale B, et al. (2006) The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11: 934-953.
14. van der Linden I, Afman L, Heil S, Blom H, (2006) Genetic variation in genes of folate metabolism and neural-tube defect risk. ProcNutr Soc 65(2): 204-215.
15. Greene N, Stanier P, Copp A, (2009) Genetics of human neural tube defects. Hum Mol Genet 18(R2): R113-129.
16. Harris M (2009). Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants. Birth Defects Research Annals of Clinical Molecular Teratology, 85(4), 331-339.
17. van der Put N, Eskes T, Blom H, (1997) Is the common 677C->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Quarterly J Med 90(2): 111-115.
18. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R, (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64(3): 169-172.
19. Trembath D, Sherbondy A, VanDyke D, Shaw G, Todoroff K, et al. (1999) Analysis of select folate pathway genes, PAX3 and Human T in a midwestern neural tube defect population. Teratol 59: 331-341.
20. Moretti P, Peters S, Del Gaudio D, Sahoo T, Hyland K, et al. (2008) Brief report: autistic symptoms, developmental regression, mental retardation, epilepsy, and diskinesias in CNS folate deficiency. J Autism Develop Disord, 38(6), 1170-1177.
21. Morris M, Jacques P, Rosenberg I, Selhub J, (2001) Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 73(5): 927-933.
22. de Lau L, Refsum H, Smith A, Johnson C, Breteler M, (2007) Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am J Clin Nutrit 86(3): 728-734.
23. Malouf R, Grimley Evans J, (2008) Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Rev 8(4): CD004514.
24. de Lau L, Smith A, Refsum H, Johnson C, Breteler M, (2009) Plasma vitamin B12 status and cerebral white-matter lesions. J NeurosurgPsychiat 80(2): 149-157.
25. Sen A, Kanani S, (2009) Impact of iron-folic acid supplementation on cognitive abilities of school girls in Vadodara. Indian Pediatr 46(2): 849-854.
26. Tangney C, Tang Y, Evans D, Morris M, (2009) Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline. Neurol 72(4): 361-367.
27. Bussing R, Fernandez M, Harwood M, Hou W, Garvan C, et al. (2008) Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment 15(3): 317-328.
28. The MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry 56: 1073-1086.
29. Davidson C, Northrup H, King T, Fletcher JM, Townsend I, et al. (2008) Genes in glucose metabolism and association with spina bifida. Reprod Sci 15(1): 51-58.
30. Martinez D, Northrup H, Jone-Ing L, Morrison A, Fletcher JM, Tyerman M, et al. (2009) Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida. Am J Obstet Gynecol 201(394): e1-11.
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, et al. (2007) PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 81: 559-575.
32. Crider KS, Bailey LB, Berry RJ, (2011) Folic acid food fortification - Its history, effect, concerns, and future directions. Nutrients 3: 370-384.
33. Lakhan SE, Vieira KF, (2008) Nutritional therapies for mental disorders. Nutr J 7: 2.
34. Dennis M, Landry S, Barnes M, Fletcher JM, (2006) A model of neurocognitive function in spina bifida over the life span. J Intl Neuropsychol Soc 12: 285-296.
35. Dennis M, Barnes M, (2010) The cognitive phenotype of spina bifida myelomeningocele. Dev Dis Res Rev 16(1): 31-39.
36. Dennis M, Sinopoli K, Fletcher JM, Schachar R, (2008) Puppets, robots, critics, and actors within a taxonomy of attention for developmental disorders. J Intl Neuropsychol Soc 14: 673-690.
37. Dennis M, Edelstein K, Copeland K, Frederick J, Francis D, et al. (2005) Covert orienting to exogenous and endogenous cues in children with spina bifida. Neuropsychologia 43(6): 976-987.
38. Swartwout M, Cirino P, Hampson A, Fletcher JM, Brandt M, et al. (2008) Sustained attention in children with two etiologies of early hydrocephalus. Neuropsych 22(6): 765-775.
39. CDC (2011) Summary Health Statistics for U.S. Children: National Health Interview Survey, 2010, Vital and Health Statistics. Series 10, Number 250. Appendix III, table VI.
40. Giralt J, Ortega J, Olive T, Verges R, Forio I, et al. (1992) Long-term neuropsychologic sequelae of childhood leukemia: comparison of two CNS prophylactic regimens. Intl J Rad Oncol Biol Phys 24(1): 49-53.
41. Maria B, Dennis M, Obonsawain M, (1993) Severe permanent encephalopathy in acute lymphoblastic leukemia. Can J Neurol Sci 20(3): 199-205.
42. Krull K, Brouwers M, Jain N, Zhang L, Bomgaars L, et al. (2008) Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr 152: 101-105.
43. Gokcen C, Kocak N, Pekgor A, (2011) Methylenetetrahydrofolate reductase gene polymorphisms in children with attention deficit hyperactivity disorder. Intl J Med Sci 8(7): 523-528.
44. Ergul E, Sazci A, Kara I, (2012) Methylenetetrahydrofolate reductase gene polymorphisms in Turkish children with attention-deficit/hyperactivity disorder. Genet Test Mol Biomarkers 16(1): 67-69.
45. Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, et al. (2012) Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 44(1): 78-86.
46. Wu C, Gong Y, Sun A, Zhang Y, Zhang C, et al. (2012) The human MTHFR rs4846049 polymorphism increases coronary heart disease risk through modifying miRNA binding. Nutr Metab Cardiovasc Dis May 28 [Epub ahead of print]. PMID 22647417.
47. Koturbash I, Melnyk S, James SJ, Beland FA, Pogribny IP (2011) Role of epigenetic and miR-22 and miR-29b alterations in the downregulation of Mat1a and Mthfr genes in early preneoplastic livers in rats induced by 2-acetylaminofluorene. Mol Carcinog, 2011 Dec 27. doi: 10.1002/mc.21861. [Epub ahead of print].